RIGEL PHARMACEUTICALS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -125.8% | -125.8% | -88.6% |
| FY2017 | -77.5% | -77.5% | -65.5% |
| FY2018 | -64.1% | -64.1% | -50.7% |
| FY2019 | -124.3% | -104.8% | -45.3% |
| FY2020 | -87.4% | -55.1% | -26.9% |
| FY2021 | -59.0% | -35.6% | -10.7% |
| FY2022 | 430.2% | -222.0% | -43.6% |
| FY2023 | 87.6% | -80.0% | -21.4% |
| FY2024 | 531.8% | 27.6% | 10.7% |
| FY2025 | 93.8% | 82.7% | 71.5% |